<DOC>
	<DOCNO>NCT00845611</DOCNO>
	<brief_summary>The purpose study evaluate safety immune response peptide ( URLC10 ) emulsify Montanide ISA51 treat patient unresectable , advanced recurrent gastric cancer .</brief_summary>
	<brief_title>Human Leukocyte Antigen ( HLA ) - A*2402 Restricted Peptide Vaccine Therapy Patients With Advanced Gastric Cancer</brief_title>
	<detailed_description>URLC10 identify cancer specific molecule especially non small cell lung cancer use genome-wide expression profile analysis cDNA microarray technique . In prior study , show URLC10 upregulated esophageal cancer gastric cancer cancer . The investigator identify peptide derive protein significantly induce effective tumor specific CTL response vitro . According finding , trial , investigator evaluate safety , immunological clinical response URLC10 peptide vaccine patient gastric cancer . Patients vaccinate one week eighth vaccine vaccinate two week ninth vaccine . On vaccination day , URLC10 peptide ( 1mg ) mixed Montanide ISA 51 administer endodermic injection</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Patients must Advanced recurrent gastric cancer , treatment fail , situation effective therapy available , refuse due severe adverse effect chemotherapy 2. WHO performance status 0 2 3 . Age ≥ 20 year , ≤80 year 4 . The patient need measurable disease , must disease effect judgment possible 5 . Passing previous treatment two week . 6 . Expected survival least 3 month 7 . WBC≥ 1,500/mm³ WBC≤ 15,000/mm³ Platelet count ≥ 50,000/mm³ Total bilirubin≤ 3 x institutional normal upper limit AST , ALT ≤ 3 x institutional normal upper limit Creatinine ≤ 3 x institutional normal upper limit 8 . Patients must HLAA2402 9 . Able willing give valid write informed consent 1 . Pregnancy , Promise pregnancy , Hope pregnancy , Breastfeeding 2 . Serious infection require antibiotic 3 . Concurrent treatment steroid immunosuppressing agent 4 . Decision unsuitableness principal investigator physicianincharge</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>peptide vaccine</keyword>
	<keyword>URLC10</keyword>
</DOC>